Coastlands Capital LP → Pasithea Therapeutics Corp. KTTAW

Stake: — Shares: — Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 6.96

25,267 shares short · -34.7% vs prior

Other 13D/G Filings on Pasithea Therapeutics Corp.

Filed	Form	Filer	Stake	Shares
2026-06-23	SCHEDULE 13G	Stonepine Capital Management, LLC	—	—	view →
2025-03-06	SCHEDULE	STEINMAN LAWRENCE	3.10%	83,858	view →
2022-09-01	SC	Camac Fund, LP	—	—	view →
2022-06-27	SC	Camac Fund, LP	—	—	view →

Other Filings by Coastlands Capital LP

Filed	Form	Issuer	Stake	Shares
2026-07-01	SCHEDULE 13G/A	Adial Pharmaceuticals, Inc. ADIL	—	—	view →
2026-06-24	SCHEDULE 13G	Adial Pharmaceuticals, Inc. ADIL	—	—	view →
2026-06-17	SCHEDULE 13G	Eloxx Pharmaceuticals, Inc. ELOX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →